Thomas Müller Selected Research

Dopamine Agents (Dopaminergic Agents)

10/2017	Current and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson's disease.
12/2007	Relating mode of action to clinical practice: dopaminergic agents in Parkinson's disease.
1/2007	Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
9/2006	Levodopa, motor fluctuations and dyskinesia in Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Müller Research Topics

Disease

116	Parkinson Disease (Parkinson's Disease) 01/2022 - 04/2002
33	Rabies (Hydrophobia) 01/2022 - 09/2001
28	Neoplasms (Cancer) 12/2022 - 05/2002
23	Infections 02/2021 - 01/2011
18	Diarrhea 01/2022 - 02/2009
12	Thrombosis (Thrombus) 08/2022 - 05/2011
11	Dyskinesias (Dyskinesia) 01/2022 - 09/2002
10	Hemorrhage 01/2021 - 04/2011
9	COVID-19 08/2022 - 07/2020
9	Multiple Sclerosis 12/2019 - 07/2003
9	Respiratory Insufficiency (Respiratory Failure) 02/2019 - 01/2009
8	Microvillus inclusion disease 01/2022 - 10/2008
8	Inflammation (Inflammations) 12/2021 - 04/2004
8	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 11/2008
8	Disease Progression 01/2021 - 06/2013
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 12/2002
6	Wounds and Injuries (Trauma) 03/2022 - 06/2013
6	Renal Insufficiency (Renal Failure) 12/2020 - 11/2002
6	Pain (Aches) 01/2019 - 04/2006
5	Neoplasm Metastasis (Metastasis) 12/2022 - 06/2012
5	Neuroblastoma 12/2022 - 05/2008
5	Heart Failure 02/2019 - 09/2003
5	Polyneuropathies (Polyneuropathy) 05/2013 - 06/2006
4	Hepatolenticular Degeneration (Wilson's Disease) 01/2022 - 04/2004
4	Liver Diseases (Liver Disease) 01/2021 - 04/2004
4	Critical Illness (Critically Ill) 01/2021 - 03/2013
4	Cardiogenic Shock 08/2020 - 12/2011
4	Pancreatitis 01/2019 - 09/2004
4	Nausea 01/2019 - 05/2013
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2018 - 01/2016
4	Edema (Dropsy) 01/2018 - 04/2005
4	Hypertension (High Blood Pressure) 09/2017 - 11/2002
4	Huntington Disease (Huntington's Disease) 02/2017 - 02/2004
4	Virus Diseases (Viral Diseases) 05/2014 - 08/2008
3	Leukemia 01/2021 - 03/2007
3	Respiratory Acidosis 01/2019 - 01/2012
3	Hypoxia (Hypoxemia) 01/2019 - 09/2009
3	Breast Neoplasms (Breast Cancer) 01/2018 - 02/2014

Drug/Important Bio-Agent (IBA)

65	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 05/2002
25	Pharmaceutical PreparationsIBA 12/2022 - 04/2002
18	VaccinesIBA 01/2021 - 09/2001
17	Carbidopa (Lodosyn)FDA LinkGeneric 01/2022 - 03/2006
16	Proteins (Proteins, Gene)FDA Link 03/2022 - 11/2002
14	HomocysteineIBA 01/2022 - 02/2004
12	Dopamine (Intropin)FDA LinkGeneric 05/2019 - 04/2002
10	SodiumIBA 01/2022 - 02/2009
9	AntibodiesIBA 02/2022 - 06/2002
9	entacapone (Comtan)FDA Link 01/2022 - 03/2006
9	Monoamine Oxidase (MAO)IBA 09/2020 - 05/2008
8	Rabies Vaccines (Rabies Vaccine)FDA Link 01/2022 - 01/2009
8	AntigensIBA 01/2021 - 03/2009
8	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2020 - 03/2006
7	Dopamine Agonists (Dopamine Agonist)IBA 01/2021 - 12/2002
7	safinamideIBA 01/2020 - 09/2013
7	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 07/2016 - 07/2003
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2002
6	Myosins (Myosin)IBA 01/2022 - 10/2008
6	SteroidsIBA 02/2021 - 07/2003
6	EnzymesIBA 01/2020 - 06/2003
5	Antiviral Agents (Antivirals)IBA 01/2022 - 08/2008
5	CopperIBA 01/2022 - 02/2003
5	Amantadine (Aman)FDA LinkGeneric 01/2022 - 03/2003
5	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020 - 09/2010
5	Selegiline (E250)FDA LinkGeneric 10/2014 - 05/2002
4	Hemoglobins (Hemoglobin)IBA 01/2021 - 05/2014
4	Fibrinogen (Factor I)FDA Link 01/2021 - 04/2011
4	Neutralizing AntibodiesIBA 12/2018 - 01/2011
4	Dopamine Agents (Dopaminergic Agents)IBA 10/2017 - 09/2006
4	Dopa DecarboxylaseIBA 09/2017 - 05/2002
4	cysteinylglycine (Cys-Gly)IBA 05/2017 - 02/2011
4	Peptides (Polypeptides)IBA 01/2017 - 03/2009
4	Triamcinolone (Aristocort)FDA Link 07/2016 - 01/2014
4	Cysteine (L-Cysteine)FDA Link 04/2016 - 04/2009
4	TabletsIBA 06/2014 - 03/2006
4	Cisplatin (Platino)FDA LinkGeneric 05/2013 - 03/2007
3	Adenosine Triphosphatases (ATPase)IBA 01/2022 - 11/2002
3	3-methoxytyrosineIBA 01/2022 - 09/2011
3	Retinaldehyde (Retinal)IBA 08/2021 - 08/2014
3	Biological ProductsIBA 01/2021 - 11/2009
3	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 05/2011
3	SolutionsIBA 10/2020 - 11/2018
3	AntioxidantsIBA 10/2020 - 06/2013
3	Apomorphine FDA Link 10/2020 - 05/2003
3	Monoclonal AntibodiesIBA 01/2020 - 05/2008
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 06/2009
3	rotigotine FDA Link 01/2018 - 03/2015

Therapy/Procedure

45	Therapeutics 06/2022 - 05/2003
32	Extracorporeal Membrane Oxygenation 01/2021 - 11/2008
14	Drug Therapy (Chemotherapy) 01/2022 - 01/2004
6	Oxygenators 08/2022 - 06/2014
6	Membrane Oxygenators (Membrane Oxygenator) 01/2018 - 11/2008
5	Transplantation 01/2021 - 11/2002
5	Cardiopulmonary Resuscitation (CPR) 12/2020 - 11/2012
5	Cannula 01/2019 - 12/2011
4	Kidney Transplantation 01/2022 - 11/2002
4	Critical Care (Surgical Intensive Care) 01/2022 - 09/2009
4	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2020 - 11/2002
4	Liver Transplantation 01/2019 - 09/2012
3	Length of Stay 08/2022 - 01/2004
3	Lasers (Laser) 11/2020 - 03/2009